Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01FD01	TRAZIMERA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for solution	28,550,630 L.L
L01FF05	TECENTRIQ	BioTech	Atezolizumab - 1200mg	1200mg	Injectable concentrate for solution	384,573,023 L.L
L01FF05	TECENTRIQ	BioTech	Atezolizumab - 1200mg	1200mg	Injectable concentrate for solution	384,573,023 L.L
L01XK04	TALZENNA	B	Talazoparib - 1mg	1mg	Capsule	401,512,167 L.L
L01XK04	TALZENNA	B	Talazoparib - 0.25mg	0.25mg	Capsule	133,836,699 L.L
L04AA04	THYMOGLOBULINE 5mg/ml	BioTech	Rabbit anti-human thymocyte immunoglobulin - 25mg/5ml	25mg/5ml	Injectable powder for solution	20,474,471 L.L
L04AA31	TERAGIO	G	Teriflunomide - 14mg	14mg	Tablet	49,451,224 L.L
L04AA31	TERAGIO	G	Teriflunomide - 14mg	14mg	Tablet	23,076,914 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	85,080,792 L.L
L04AX02	THALIDOMIDE CELGENE	B	Thalidomide - 50mg	50mg	Capsule	27,387,764 L.L
L04AX02	THALIDOMIDE BMS	B	Thalidomide - 50mg	50mg	Capsule	27,387,764 L.L
L04AX07	TECFEO 240	G	Dimethyl Fumarate - 240mg	240mg	Capsule, delayed release	67,784,092 L.L
N05AX13	TREVICTA	B	Paliperidone - 175mg	175mg	Injectable suspension, prolonged release	44,095,203 L.L
N05AX13	TREVICTA	B	Paliperidone - 263mg	263mg	Injectable suspension, prolonged release	58,466,963 L.L
N05AX13	TREVICTA	B	Paliperidone - 350mg	350mg	Injectable suspension, prolonged release	68,926,445 L.L
N05AX13	TREVICTA	B	Paliperidone - 525mg	525mg	Injectable suspension, prolonged release	77,571,160 L.L

...